These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29588189)

  • 1. Podoplanin expression as a predictive marker of dysplasia in oral leukoplakia.
    Gissi DB; Gabusi A; Tarsitano A; Luccarini L; Morandi L; Montebugnoli L
    J Craniomaxillofac Surg; 2018 May; 46(5):759-764. PubMed ID: 29588189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podoplanin expression in oral leukoplakia─a prospective study.
    Grochau KJ; Safi AF; Drebber U; Grandoch A; Zöller JE; Kreppel M
    J Craniomaxillofac Surg; 2019 Mar; 47(3):505-509. PubMed ID: 30638740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podoplanin Expression Independently and Jointly with Oral Epithelial Dysplasia Grade Acts as a Potential Biomarker of Malignant Transformation in Oral Leukoplakia.
    Monteiro L; do Amaral B; Delgado L; Garcês F; Salazar F; Pacheco JJ; Lopes C; Warnakulasuriya S
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
    D'souza B; Nayak R; Kotrashetti VS
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
    Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
    J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podoplanin expression in oral leukoplakia: tumorigenic role.
    de Vicente JC; Rodrigo JP; Rodriguez-Santamarta T; Lequerica-Fernández P; Allonca E; García-Pedrero JM
    Oral Oncol; 2013 Jun; 49(6):598-603. PubMed ID: 23473850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
    Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
    J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in apoptosis and mitotic index, p53 and Ki67 expression in various types of oral leukoplakia.
    Kövesi G; Szende B
    Oncology; 2003; 65(4):331-6. PubMed ID: 14707453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podoplanin expression in oral leukoplakia: prognostic value and clinicopathological implications.
    Kreppel M; Kreppel B; Drebber U; Wedemayer I; Rothamel D; Zöller JE; Scheer M
    Oral Dis; 2012 Oct; 18(7):692-9. PubMed ID: 22471854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p53, p63, podoplanin and Ki-67 in recurring versus non-recurring oral leukoplakia.
    Sundberg J; Pandey S; Giglio D; Holmberg E; Kjeller G; Kovács A; Sand LP; Tokozlu B; Öhman J; Sapkota D; Hasséus B
    Sci Rep; 2021 Oct; 11(1):20781. PubMed ID: 34675318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
    Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R
    Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
    Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
    Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological and immunohistochemical study of malignant transformation of oral leukoplakia, with special reference to apoptosis-related gene products and proliferative activity.
    Nogami T; Kuyama K; Yamamoto H
    Acta Otolaryngol; 2003 Aug; 123(6):767-75. PubMed ID: 12953781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
    Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
    Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Role of p53 Protein as a Single Marker or Associated with ki67 Antigen in Oral Leukoplakia: A Retrospective Longitudinal Study.
    Gissi DB; Gabusi A; Servidio D; Cervellati F; Montebugnoli L
    Open Dent J; 2015; 9():41-5. PubMed ID: 25674170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between p62 expression and clinicopathological characteristics in oral leukoplakia.
    Yoshida T; Terabe T; Nagai H; Uchida F; Hasegawa S; Nagao T; Miyabe S; Ishibashi-Kanno N; Yamagata K; Warabi E; Gosho M; Yanagawa T; Bukawa H
    Clin Exp Dent Res; 2019 Aug; 5(4):389-397. PubMed ID: 31452949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative cell-cycle protein expression in oral cancer assessed by computer-assisted system.
    Soares CP; Zuanon JA; Teresa DB; Fregonezi PA; Neto CB; Oliveira MR; Donadi EA; Martinelli-Kläy CP; Soares EG
    Histol Histopathol; 2006 Jul; 21(7):721-8. PubMed ID: 16598671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
    Xia RH; Song XM; Wang XJ; Li J; Mao L
    PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of CA-IX as a diagnostic method for oral leukoplakia.
    Pérez-Sayáns M; Suárez-Peñaranda JM; Torres-López M; Supuran CT; Gándara-Vila P; Gayoso-Diz P; Barros-Angueira F; Gallas-Torreira M; García-García A
    Biotech Histochem; 2015 Feb; 90(2):124-31. PubMed ID: 25297562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.